Petros Pharmaceuticals (PTPI) CAO reports 636,004-share position
Rhea-AI Filing Summary
Petros Pharmaceuticals, Inc. executive Robert Weinstein, the Chief Accounting Officer, has reported his existing holdings on a Form 3. He holds a total of 636,004 shares of common stock, including restricted shares and restricted stock units.
His position includes 6,004 restricted shares, of which 3,004 are already vested and the remainder will vest on February 2, 2027. It also includes 315,000 vested restricted stock units (RSUs) and 315,000 unvested RSUs, with 2,500 scheduled to vest on July 2, 2026 and the rest on December 5, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
WEINSTEIN ROBERT
Role
Chief Accounting Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common stock | -- | -- | -- |
Holdings After Transaction:
Common stock — 636,004 shares (Direct)
Footnotes (1)
- F1. Includes (i) 6,004 restricted shares of common stock, par value $0.0001, of the Issuer, of which 3,004 shares are vested and the remainder of which will vest on February 2, 2027, (ii) 315,000 vested restricted stock units ("RSUs"), and (iii) 315,000 unvested RSUs, 2,500 of which will vest on July 2, 2026 and the remainder of which will vest on December 5, 2026.
Key Figures
Common stock holdings: 636,004 shares
Restricted shares: 6,004 shares
Vested restricted shares: 3,004 shares
+4 more
7 metrics
Common stock holdings
636,004 shares
Total common stock reported following transaction
Restricted shares
6,004 shares
Restricted common stock included in holdings
Vested restricted shares
3,004 shares
Portion of restricted shares already vested
Vested RSUs
315,000 RSUs
Restricted stock units that are vested
Unvested RSUs
315,000 RSUs
Restricted stock units not yet vested
RSUs vesting July 2, 2026
2,500 RSUs
First tranche of unvested RSUs vesting on July 2, 2026
Remaining RSUs vesting
RSUs (balance of 315,000)
Unvested RSUs vesting on December 5, 2026
Key Terms
restricted shares, restricted stock units ("RSUs"), Form 3, Chief Accounting Officer
4 terms
restricted stock units ("RSUs") financial
"315,000 vested restricted stock units ("RSUs"), and (iii) 315,000 unvested RSUs"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Form 3 regulatory
"has reported his existing holdings on a Form 3"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
Chief Accounting Officer financial
"Robert Weinstein, the Chief Accounting Officer, has reported his existing holdings"
A chief accounting officer is a senior executive responsible for overseeing a company's financial records and ensuring all accounting practices are accurate and compliant with regulations. They play a key role in preparing financial reports that help investors understand the company's financial health, much like a trusted navigator guiding a ship through complex waters. Their work ensures transparency and trust in the company's financial information.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the PTPI Form 3 filing by Robert Weinstein show?
The Form 3 shows that Chief Accounting Officer Robert Weinstein holds 636,004 shares of Petros Pharmaceuticals common stock, including restricted shares and restricted stock units. It records his existing ownership position as an insider rather than new share purchases or sales.
How many RSUs does the PTPI Chief Accounting Officer report on Form 3?
The Chief Accounting Officer reports 630,000 restricted stock units (RSUs) in total. This consists of 315,000 vested RSUs and 315,000 unvested RSUs, providing a detailed breakdown of his equity-based compensation at Petros Pharmaceuticals.
When will Robert Weinstein’s unvested PTPI RSUs vest?
Of Robert Weinstein’s 315,000 unvested RSUs, 2,500 are scheduled to vest on July 2, 2026. The remaining unvested RSUs are expected to vest on December 5, 2026, based on the vesting schedule disclosed in the Form 3 footnote.